These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4079044)

  • 1. [Evaluation of treatment planning of radiotherapy for lung cancer].
    Okumura Y; Takao H; Okajima S; Morita K
    Gan No Rinsho; 1985 Sep; 31(12):1560-2. PubMed ID: 4079044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer.
    Liu HH; Wang X; Dong L; Wu Q; Liao Z; Stevens CW; Guerrero TM; Komaki R; Cox JD; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1268-79. PubMed ID: 15001272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases.
    Yartsev S; Chen J; Yu E; Kron T; Rodrigues G; Coad T; Trenka K; Wong E; Bauman G; Dyk JV
    Radiother Oncol; 2006 Feb; 78(2):169-76. PubMed ID: 16413621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
    Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short course of palliative radiotherapy for inoperable non-small cell lung cancer: biologically effective dose on spinal cord.
    Plataniotis GA; Kouvaris JR; Dardoufas C; Pistevou-Gobaki K; Kouloulias V; Papadopoulos LS; Vlahos L
    Clin Oncol (R Coll Radiol); 2000; 12(5):335. PubMed ID: 11315722
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute and late toxicities in thoracic irradiation].
    Chapet O
    Cancer Radiother; 2007; 11(1-2):92-100. PubMed ID: 17291806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A treatment planning study evaluating a 'simultaneous integrated boost' technique for accelerated radiotherapy of stage III non-small cell lung cancer.
    Dirkx ML; van Sörnsen De Koste JR; Senan S
    Lung Cancer; 2004 Jul; 45(1):57-65. PubMed ID: 15196735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two dimensional and three dimensional radiotherapy treatment planning in locally advanced non-small cell lung cancer treated with continuous hyperfractionated accelerated radiotherapy weekend less.
    Wilson EM; Joy Williams F; Lyn BE; Aird EG
    Radiother Oncol; 2005 Mar; 74(3):307-14. PubMed ID: 15763312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment.
    Schwarz M; Van der Geer J; Van Herk M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1260-9. PubMed ID: 16798418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.
    Schwarz M; Alber M; Lebesque JV; Mijnheer BJ; Damen EM
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):561-70. PubMed ID: 15890601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer.
    Miller KL; Shafman TD; Marks LB
    Semin Radiat Oncol; 2004 Oct; 14(4):298-307. PubMed ID: 15558504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
    Koelbl O; Krieger T; Haedinger U; Sauer O; Flentje M
    Strahlenther Onkol; 2004 Dec; 180(12):783-8. PubMed ID: 15592698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radiotherapy and chemotherapy on sensory deficits from spinal cord damage.
    Nieder C; Andratschke NH; Grosu AL
    Acta Oncol; 2005; 44(4):412-4. PubMed ID: 16120551
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of radiation therapy in the management of non-small cell lung cancer.
    Machtay M; Friedberg JS
    Semin Thorac Cardiovasc Surg; 1997 Jan; 9(1):80-9. PubMed ID: 9109228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis, diagnostics and treatment of radiation pneumonitis induced by radiotherapy of lung cancer].
    Kiazimov KI
    Georgian Med News; 2009 Sep; (174):115-8. PubMed ID: 19801749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry in translation total body irradiation technique: a computer treatment planning approach and an experimental study concerning lung sparing.
    Zabatis Ch; Koligliatis T; Xenofos S; Pistevou K; Psarakos K; Haritanti A; Beroukas K
    J BUON; 2008; 13(2):253-62. PubMed ID: 18555474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment planning for dose escalation in non-small cell lung cancer (NSCLC).
    Schild SE; Korte SM; Wong WW; Vora SA; Younggren JA; Ezzell GA
    Med Dosim; 2004; 29(3):196-203. PubMed ID: 15324916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.